Page 218 - Remedial Andrology

984. Ventimiglia, E., et al. Peyronie’s disease and autoimmunity-a real-life clinical study and
comprehensive review. J Sex Med, 2015. 12: 1062.
https://pubmed.ncbi.nlm.nih.gov/25630575
985. Kadioglu, A., et al. A retrospective review of 307 men with Peyronie’s disease. J Urol, 2002. 168: 1075.
https://pubmed.ncbi.nlm.nih.gov/12187226
986. Rhoden, E.L., et al. A cross-sectional study for the analysis of clinical, sexual and laboratory
conditions associated to Peyronie’s disease. J Sex Med, 2010. 7: 1529.
https://pubmed.ncbi.nlm.nih.gov/19912489
987. Cavallini, G., et al. Association between Peyronie disease and low serum testosterone levels:
detection and therapeutic considerations. J Androl, 2012. 33: 381.
https://pubmed.ncbi.nlm.nih.gov/21719695
988. Bjekic, M.D., et al. Risk factors for Peyronie’s disease: a case-control study. BJU Int, 2006. 97: 570.
https://pubmed.ncbi.nlm.nih.gov/16469028
989. Carrieri, M.P., et al. A case-control study on risk factors for Peyronie’s disease. J Clin Epidemiol,
1998. 51: 511.
https://pubmed.ncbi.nlm.nih.gov/9636000
990. Deveci, S., et al. Defining the clinical characteristics of Peyronie’s disease in young men. J Sex Med,
2007. 4: 485.
https://pubmed.ncbi.nlm.nih.gov/17081219
991. Shindel, A.W., et al. Prevalence of Peyronie’s Disease-Like Symptoms in Men Presenting With
Dupuytren Contractures. Sex Med, 2017. 5: e135.
https://pubmed.ncbi.nlm.nih.gov/28676223
992. Mohede, D.C.J., et al. Prevalence of Peyronie and Ledderhose Diseases in a Series of 730 Patients
with Dupuytren Disease. Plast Reconstr Surg, 2020. 145: 978.
https://pubmed.ncbi.nlm.nih.gov/32221218
993. Ralph, D., et al. The management of Peyronie’s disease: evidence-based 2010 guidelines. J Sex
Med, 2010. 7: 2359.
https://pubmed.ncbi.nlm.nih.gov/20497306
994. Gelbard, M.K., et al. The natural history of Peyronie’s disease. J Urol, 1990. 144: 1376.
https://pubmed.ncbi.nlm.nih.gov/2231932
995. Mulhall, J.P., et al. An analysis of the natural history of Peyronie’s disease. J Urol, 2006. 175: 2115.
https://pubmed.ncbi.nlm.nih.gov/16697815
996. Berookhim, B.M., et al. Deformity stabilization and improvement in men with untreated Peyronie’s
disease. BJU Int, 2014. 113: 133.
https://pubmed.ncbi.nlm.nih.gov/24053665
997. Pryor, J.P., et al. Clinical presentations of Peyronie’s disease. Int J Impot Res, 2002. 14: 414.
https://pubmed.ncbi.nlm.nih.gov/12454695
998. Nelson, C.J., et al. The chronology of depression and distress in men with Peyronie’s disease. J Sex
Med, 2008. 5: 1985.
https://pubmed.ncbi.nlm.nih.gov/18554257
999. Hellstrom, W.J., et al. Bother and distress associated with Peyronie’s disease: validation of the
Peyronie’s disease questionnaire. J Urol, 2013. 190: 627.
https://pubmed.ncbi.nlm.nih.gov/23376705
1000. Russo, G.I., et al. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie’s Disease: A
Systematic Review of the Literature. Eur Urol, 2018. 74: 767.
https://pubmed.ncbi.nlm.nih.gov/30237020
1001. Masterson, T.A., et al. Characteristics predictive of response to collagenase clostridium histolyticum
for Peyronie’s disease: a review of the literature. World J Urol, 2019.
https://pubmed.ncbi.nlm.nih.gov/31250098
1002. Chung, E., et al. Evidence-Based Management Guidelines on Peyronie’s Disease. J Sex Med, 2016.
13: 905.
https://pubmed.ncbi.nlm.nih.gov/27215686
1003. Bekos, A., et al. The natural history of Peyronie’s disease: an ultrasonography-based study. Eur Urol,
2008. 53: 644.
https://pubmed.ncbi.nlm.nih.gov/17673362
1004. Greenfield, J.M., et al. Factors affecting the loss of length associated with tunica albuginea plication
for correction of penile curvature. J Urol, 2006. 175: 238.
https://pubmed.ncbi.nlm.nih.gov/16406919
1005. Liguori, G., et al. Objective measurements of the penile angulation are significantly different than
self-estimated magnitude among patients with penile curvature. Int Braz J Urol, 2018. 44: 555.
https://pubmed.ncbi.nlm.nih.gov/29570261

SEXUAL AND REPRODUCTIVE HEALTH - MARCH 2021 217